Overview

Phase 1/2 Dose Finding and Safety Study of Ibrutinib in Pediatric Subjects With Chronic Graft Versus Host Disease (cGVHD)

Status:
Active, not recruiting
Trial end date:
2026-01-04
Target enrollment:
Participant gender:
Summary
Dose Finding and Safety Study of Ibrutinib in Pediatric Subjects with Chronic Graft Versus Host Disease (cGVHD)
Phase:
Phase 1/Phase 2
Details
Lead Sponsor:
Pharmacyclics LLC.
Collaborator:
Janssen Research & Development, LLC